#era26 — Public Fediverse posts

No more growth in #KidneyWk numbers over last 3 years 12216 in 2023 12123 in 2024 11981 in 2025 OTOH #ERA26 had 10760 Wager ERA > KidneyWk before 2030

RE: https://bsky.app/profile/did:plc:33h4q6nw674jdcwfxaq2m2nl/post/3mj4apv5ukk2i

habe mir gerade https://fgsv-veranstaltungen.de/ #fsgv das Programm angeschaut. Sollte es wirklich war sein, dass es dieses Jahr noch eine neue #era26 geben sollte ? Reine Spekulation meinerseits, aber es gibt einen Vortrag: Neue Empfehlungen für Radverkehrsanlagen (ERA 26)
Dipl.-Ing. Michael Haase

Weiß die #fahrradbubble oder der @ADFC mehr ?

habe mir gerade https://fgsv-veranstaltungen.de/ #fsgv das Programm angeschaut. Sollte es wirklich war sein, dass es dieses Jahr noch eine neue #era26 geben sollte ? Reine Spekulation meinerseits, aber es gibt einen Vortrag: Neue Empfehlungen für Radverkehrsanlagen (ERA 26)
Dipl.-Ing. Michael Haase

Weiß die #fahrradbubble oder der @ADFC mehr ?

habe mir gerade https://fgsv-veranstaltungen.de/ #fsgv das Programm angeschaut. Sollte es wirklich war sein, dass es dieses Jahr noch eine neue #era26 geben sollte ? Reine Spekulation meinerseits, aber es gibt einen Vortrag: Neue Empfehlungen für Radverkehrsanlagen (ERA 26)
Dipl.-Ing. Michael Haase

Weiß die #fahrradbubble oder der @ADFC mehr ?

habe mir gerade https://fgsv-veranstaltungen.de/ #fsgv das Programm angeschaut. Sollte es wirklich war sein, dass es dieses Jahr noch eine neue #era26 geben sollte ? Reine Spekulation meinerseits, aber es gibt einen Vortrag: Neue Empfehlungen für Radverkehrsanlagen (ERA 26)
Dipl.-Ing. Michael Haase

Weiß die #fahrradbubble oder der @ADFC mehr ?

habe mir gerade https://fgsv-veranstaltungen.de/ #fsgv das Programm angeschaut. Sollte es wirklich war sein, dass es dieses Jahr noch eine neue #era26 geben sollte ? Reine Spekulation meinerseits, aber es gibt einen Vortrag: Neue Empfehlungen für Radverkehrsanlagen (ERA 26)
Dipl.-Ing. Michael Haase

Weiß die #fahrradbubble oder der @ADFC mehr ?

According to Dr Fervenza it seems MENTOR was not enough as it was ‘registered’ for drug approval 🤷🏽‍♂️ #ERA26

The Finerenone publishing juggernaut Does feel infinite www.thelancet.com/journals/lan... in the Lancet - combining FIDELIO, FIGARO and now FIND CKD (so not FINEARTS) #ERA26 simulpub

Efficacy and safety of fineren...

The Finerenone publishing juggernaut

Does feel infinite

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01009-3/abstract in the Lancet - combining FIDELIO, FIGARO and now FIND CKD (so not FINEARTS)

#ERA26 simulpub

The Finerenone publishing juggernaut

Does feel infinite

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01009-3/abstract in the Lancet - combining FIDELIO, FIGARO and now FIND CKD (so not FINEARTS)

#ERA26 simulpub

The Finerenone publishing juggernaut

Does feel infinite

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01009-3/abstract in the Lancet - combining FIDELIO, FIGARO and now FIND CKD (so not FINEARTS)

#ERA26 simulpub

The Finerenone publishing juggernaut

Does feel infinite

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01009-3/abstract in the Lancet - combining FIDELIO, FIGARO and now FIND CKD (so not FINEARTS)

#ERA26 simulpub

The Finerenone publishing juggernaut

Does feel infinite

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01009-3/abstract in the Lancet - combining FIDELIO, FIGARO and now FIND CKD (so not FINEARTS)

#ERA26 simulpub

And the GN subgroup from FIND CKD

Again somewhat underwhelming but small and significant benefit

https://jamanetwork.com/journals/jama/fullarticle/2850124 in JAMA

#ERA26

And the GN subgroup from FIND CKD

Again somewhat underwhelming but small and significant benefit

https://jamanetwork.com/journals/jama/fullarticle/2850124 in JAMA

#ERA26

And the GN subgroup from FIND CKD

Again somewhat underwhelming but small and significant benefit

https://jamanetwork.com/journals/jama/fullarticle/2850124 in JAMA

#ERA26

And the GN subgroup from FIND CKD

Again somewhat underwhelming but small and significant benefit

https://jamanetwork.com/journals/jama/fullarticle/2850124 in JAMA

#ERA26

And the GN subgroup from FIND CKD Again somewhat underwhelming but small and significant benefit jamanetwork.com/journals/jam... in JAMA #ERA26

Validate User

And the GN subgroup from FIND CKD

Again somewhat underwhelming but small and significant benefit

https://jamanetwork.com/journals/jama/fullarticle/2850124 in JAMA

#ERA26

Simulpub number 6 at #ERA26

Obi beats tacrolimus in membranous nephropathy

https://www.nejm.org/doi/full/10.1056/NEJMoa2602678?query=RP in NEJM

No surprise after MENTOR

Simulpub number 6 at #ERA26

Obi beats tacrolimus in membranous nephropathy

https://www.nejm.org/doi/full/10.1056/NEJMoa2602678?query=RP in NEJM

No surprise after MENTOR

Simulpub number 6 at #ERA26

Obi beats tacrolimus in membranous nephropathy

https://www.nejm.org/doi/full/10.1056/NEJMoa2602678?query=RP in NEJM

No surprise after MENTOR

Simulpub number 6 at #ERA26 Obi beats tacrolimus in membranous nephropathy www.nejm.org/doi/full/10.... in NEJM No surprise after MENTOR

Obinutuzumab or Tacrolimus in ...

Simulpub number 6 at #ERA26

Obi beats tacrolimus in membranous nephropathy

https://www.nejm.org/doi/full/10.1056/NEJMoa2602678?query=RP in NEJM

No surprise after MENTOR

Simulpub number 6 at #ERA26

Obi beats tacrolimus in membranous nephropathy

https://www.nejm.org/doi/full/10.1056/NEJMoa2602678?query=RP in NEJM

No surprise after MENTOR

Another #ERA26 simulpub

Effect of empa/finerenone on BP, yet another splice from CONFIDENCE

https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.126.27036

(If you want a BP effect, use Spiro)

Another #ERA26 simulpub

Effect of empa/finerenone on BP, yet another splice from CONFIDENCE

https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.126.27036

(If you want a BP effect, use Spiro)

Another #ERA26 simulpub

Effect of empa/finerenone on BP, yet another splice from CONFIDENCE

https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.126.27036

(If you want a BP effect, use Spiro)

Another #ERA26 simulpub Effect of empa/finerenone on BP, yet another splice from CONFIDENCE www.ahajournals.org/doi/10.1161/... (If you want a BP effect, use Spiro)

Safety and Synergy of Finereno...

Another #ERA26 simulpub

Effect of empa/finerenone on BP, yet another splice from CONFIDENCE

https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.126.27036

(If you want a BP effect, use Spiro)

Another #ERA26 simulpub

Effect of empa/finerenone on BP, yet another splice from CONFIDENCE

https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.126.27036

(If you want a BP effect, use Spiro)

And FIND CKD is live already on NEJM

https://www.nejm.org/doi/full/10.1056/NEJMoa2604625?query=featured_home

#ERA26

And FIND CKD is live already on NEJM

https://www.nejm.org/doi/full/10.1056/NEJMoa2604625?query=featured_home

#ERA26

And FIND CKD is live already on NEJM

https://www.nejm.org/doi/full/10.1056/NEJMoa2604625?query=featured_home

#ERA26

And FIND CKD is live already on NEJM www.nejm.org/doi/full/10.... #ERA26

Finerenone in Persons with Chr...

And FIND CKD is live already on NEJM

https://www.nejm.org/doi/full/10.1056/NEJMoa2604625?query=featured_home

#ERA26

And FIND CKD is live already on NEJM

https://www.nejm.org/doi/full/10.1056/NEJMoa2604625?query=featured_home

#ERA26

For background see @[email protected] rounds for us from 3 years ago youtu.be/NAySJkiwpCM?... #NephGR #ERA26

AntiThrombotic Therapy in Adva...

Final GFR results from Atrasentan (ALIGN) in the Lancet

Underwhelming to me - the Flozin + Atrasentan looks pretty good OTOH

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00960-8/abstract

Simulpubs from #ERA26

Final GFR results from Atrasentan (ALIGN) in the Lancet

Underwhelming to me - the Flozin + Atrasentan looks pretty good OTOH

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00960-8/abstract

Simulpubs from #ERA26

Final GFR results from Atrasentan (ALIGN) in the Lancet

Underwhelming to me - the Flozin + Atrasentan looks pretty good OTOH

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00960-8/abstract

Simulpubs from #ERA26

Final GFR results from Atrasentan (ALIGN) in the Lancet

Underwhelming to me - the Flozin + Atrasentan looks pretty good OTOH

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00960-8/abstract

Simulpubs from #ERA26

Final GFR results from Atrasentan (ALIGN) in the Lancet

Underwhelming to me - the Flozin + Atrasentan looks pretty good OTOH

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00960-8/abstract

Simulpubs from #ERA26

Final GFR results from Atrasentan (ALIGN) in the Lancet Underwhelming to me - the Flozin + Atrasentan looks pretty good OTOH www.thelancet.com/journals/lan... Simulpubs from #ERA26

Atrasentan in patients with Ig...

Unlike COMPASS, TRACK demonstrates rivaroxaban doesn’t have the same CV benefit in CKD jamanetwork.com/journals/jam... Simultaneous pubs from #ERA26

Low-Dose Rivaroxaban and Cardi...

Unlike COMPASS, TRACK demonstrates rivaroxaban doesn’t have the same CV benefit in CKD

https://jamanetwork.com/journals/jama/fullarticle/2850100

Simultaneous pubs from #ERA26

Unlike COMPASS, TRACK demonstrates rivaroxaban doesn’t have the same CV benefit in CKD

https://jamanetwork.com/journals/jama/fullarticle/2850100

Simultaneous pubs from #ERA26

Unlike COMPASS, TRACK demonstrates rivaroxaban doesn’t have the same CV benefit in CKD

https://jamanetwork.com/journals/jama/fullarticle/2850100

Simultaneous pubs from #ERA26

Unlike COMPASS, TRACK demonstrates rivaroxaban doesn’t have the same CV benefit in CKD

https://jamanetwork.com/journals/jama/fullarticle/2850100

Simultaneous pubs from #ERA26

Unlike COMPASS, TRACK demonstrates rivaroxaban doesn’t have the same CV benefit in CKD

https://jamanetwork.com/journals/jama/fullarticle/2850100

Simultaneous pubs from #ERA26

#ERA26 simultaneous pubs

From Ed Fu and colleagues in JAMA

https://jamanetwork.com/journals/jama/fullarticle/2850099

Measured GFR vs eGFR
mGFR < 60 makes sense
eGFR cr or cys under/overestimates risks

#ERA26 simultaneous pubs

From Ed Fu and colleagues in JAMA

https://jamanetwork.com/journals/jama/fullarticle/2850099

Measured GFR vs eGFR
mGFR < 60 makes sense
eGFR cr or cys under/overestimates risks

#ERA26 simultaneous pubs

From Ed Fu and colleagues in JAMA

https://jamanetwork.com/journals/jama/fullarticle/2850099

Measured GFR vs eGFR
mGFR < 60 makes sense
eGFR cr or cys under/overestimates risks

#ERA26 simultaneous pubs From Ed Fu and colleagues in JAMA jamanetwork.com/journals/jam... Measured GFR vs eGFR mGFR < 60 makes sense eGFR cr or cys under/overestimates risks

Measured and Estimated Glomeru...

#ERA26 simultaneous pubs

From Ed Fu and colleagues in JAMA

https://jamanetwork.com/journals/jama/fullarticle/2850099

Measured GFR vs eGFR
mGFR < 60 makes sense
eGFR cr or cys under/overestimates risks

#ERA26 simultaneous pubs

From Ed Fu and colleagues in JAMA

https://jamanetwork.com/journals/jama/fullarticle/2850099

Measured GFR vs eGFR
mGFR < 60 makes sense
eGFR cr or cys under/overestimates risks

If you can’t make it to Glasgow for #ERA26, make sure to attend this webinar

RE: https://bsky.app/profile/did:plc:oql5nhfn5fazadmsvfzyxigw/post/3mnd7gtzh6i2q

The LBCT line up at #ERA26 next week Day 1: TRACK is the big one (rest is phase 2 or results we know) Day 2 is FIND CKD, TURING & MAJESTY sound interesting Day 3: GOOD IDES is negative, Ravulizumab is positive 1; HDx will torture something positive I think Lots of FOMO on missing Glasgow